Critical Analysis of the Risk/Benefit Ratio of First-Line Antibiotics Included in Guidelines for the Treatment of Community-Acquired Pneumonia

Carbonnelle, Sylviane; Lismond, Ann; Van Bambeke, Françoise; Tulkens, Paul M.

Critical Analysis of the Risk/Benefit Ratio of First-Line Antibiotics Included in Guidelines for the Treatment of Community-Acquired Pneumonia

Carbonnelle, Sylviane

;

Lismond, Ann

;

Van Bambeke, Françoise

;

Tulkens, Paul M.

(2009) 9th ISoP Annual Meeting on From Pharmacovigilance to Risk Management — Location: Reims(France) (6.October.2009)

Files

No attached file found for this publication.

Details

Authors

Carbonnelle, SylvianeUCLouvain
Author
Lismond, AnnUCLouvain
Author
Van Bambeke, FrançoiseUCLouvain
Author
Tulkens, Paul M.UCLouvain
Author

Affiliations

UCLouvainMD/FARM - Ecole de pharmacie

Citations

APA
Chicago
FWB

Carbonnelle, S., Lismond, A., Van Bambeke, F., & Tulkens, P. M. (2009). Critical Analysis of the Risk/Benefit Ratio of First-Line Antibiotics Included in Guidelines for the Treatment of Community-Acquired Pneumonia. Drug Safety, 32(10), 964-965. https://hdl.handle.net/2078.5/147292 (Original work published 2009)